StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.58MP/E –Yield –

Earnings

MacroGenics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 8, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$18.70M
-74.3% on a year earlier
EPS, Q3 FY2026
-$0.32
$0.27 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of MacroGenics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 8, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$18.70M-74.3%-$0.32Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 13, 2026after the close$20.80M+57.6%-$0.58Release
Q4 FY2025ended Dec 31, 2025Mar 9, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close$72.80M-34.2%$0.27Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close$22.20M+105.6%–Release
Q1 FY2025ended Mar 31, 2025May 13, 2025after the close$13.20M+45.1%-$0.65Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024after the close$110.70M+964.4%$0.90Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024after the close$10.80M-17.6%-$0.89Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close$9.10M-62.9%-$0.84Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

MacroGenics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When MacroGenics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases MacroGenics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. News
  5. News
  6. Results
  7. News
  8. Update
  9. Update
  10. Results
  11. Update
  12. News
  13. News
  14. Results
  15. News

See a number that looks wrong?